China
WuXi Vaccines Secures ANVISA GMP Certification For Suzhou Fill And Finish Facility
WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced that...
February 13, 2026 | News
Insilico Medicine And China Medical System Forge Multi Project AI Drug Discovery Alliance
Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Ho...
February 12, 2026 | News
Ascletis Advances ASC36 Oral Amylin Tablet With Strong Preclinical Weight Loss Data
Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC36 oral tablets achieved absolute oral bioavailability of 6% to 8% at steady...
February 12, 2026 | News
AsymBio Builds Integrated End To End Platforms To Accelerate Biopharmaceutical Development
AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms span...
February 12, 2026 | News
DIFF Biotech Secures China Clinical Approval For First Domestic Nasal Spray Influenza Vaccine
Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, ...
February 10, 2026 | News
Everest Medicines Licenses First In Class SHPT Therapy MT1013 From Micot For China And Asia Pacific
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, a...
February 10, 2026 | News
Eisai And Henlius Sign Exclusive Japan Commercialisation Deal For Anti PD 1 Antibody Serplulimab
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters: Shanghai, China, CEO:&nbs...
February 10, 2026 | News
Innovent Biologics And Eli Lilly Expand Oncology And Immunology Alliance With Global Development Model
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...
February 10, 2026 | News
Kelun Biotech Wins China Approval For Sacituzumab Tirumotecan In Advanced Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that a new indication application for its TROP2-dir...
February 09, 2026 | News
Delonix Bioworks Secures China IND Clearance For MenB Vaccine Candidate DX 104
Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines, recently announced that its Group B...
February 09, 2026 | News
China Approves Promega OncoMate MSI Companion Diagnostic For KEYTRUDA Therapy
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vi...
February 06, 2026 | News
PepLib Biotech Enters Global Peptide Drug Discovery And Licensing Collaboration With Eli Lilly
Zonsen PepLib Biotech Inc. (“PepLib”) announced that it has entered a global research and development (R&D) collaboration and license agree...
February 06, 2026 | News
Everest Medicines Secures Exclusive Asia Pacific Rights To First In Class Dual Target SHPT Therapy MT1013
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturi...
February 06, 2026 | News
Biosion Doses First Patient In Phase 1 Trial Of Novel Anti SIRPα Antibody BSI 082
Milestone validates the clinical potential of BSI-082 as a synergistic combination partner for antibody-drug conjugates (ADCs) and reinforces Biosion's "In...
February 05, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
